AI-generated summary
The authors studied whether long-pulsed 1064-nm laser treatment could improve lymphatic vessel dysfunction in rosacea, using mouse models and human lymphatic endothelial cells in vitro. They report lymphatic vessel dilation, reduced density, and impaired function in chronic rosacea-like inflammation, and that the laser mitigated this inflammation and attenuated LL-37-induced inflammatory responses in cells. Findings come from mouse and cell studies.
- Who or what was studied
- 32 female BALB/c mice, plus human lymphatic endothelial cells (HLECs) for in vitro work; the abstract also mentions individuals with rosacea in clinical observation without a stated number.
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract reports mouse and in vitro cell experiments, and does not state the number of clinical participants with rosacea.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.